ID	Database	Citation
9783642403361	ISBN	"Blau N, Duran M, Gibson KM, Dionisi-Vici C. Physician’s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases [Internet]. Springer; 2014. 867 p. Available from: https://books.google.com/books/about/Physician_s_Guide_to_the_Diagnosis_Treat.html?hl=&id=wJRBnwEACAAJ <a href=""https://openlibrary.org/search?isbn=9783642403361"" target=""_blank"" class=""external"" rel=""nofollow"">OpenLibrary</a> <a href=""https://www.worldcat.org/search?qt=wikipathways&q=isbn%3A9783642403361"" target=""_blank"" class=""external"" rel=""nofollow"">Worldcat</a>"
11073718	Pubmed	"Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria. Tomoeda K, Awata H, Matsuura T, Matsuda I, Ploechl E, Milovac T, et al. Mol Genet Metab. 2000 Nov;71(3):506–10.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/11073718"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/11073718"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/11073718"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
17560158	Pubmed	"Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III. Item CB, Mihalek I, Lichtarge O, Jalan A, Vodopiutz J, Muhl A, et al. Mol Genet Metab. 2007 Aug;91(4):379–83.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/17560158"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/17560158"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/17560158"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
20677779	Pubmed	"Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria. Brownlee JM, Heinz B, Bates J, Moran GR. Biochemistry. 2010 Aug 24;49(33):7218–26.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/20677779"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/20677779"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/20677779"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
27876694	Pubmed	"Hypersuccinylacetonaemia and normal liver function in maleylacetoacetate isomerase deficiency. Yang H, Al-Hertani W, Cyr D, Laframboise R, Parizeault G, Wang SP, et al. J Med Genet. 2017 Apr;54(4):241–7.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/27876694"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/27876694"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/27876694"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
31992763	Pubmed	"Exploring the therapeutic potential of modern and ancestral phenylalanine/tyrosine ammonia-lyases as supplementary treatment of hereditary tyrosinemia. Hendrikse NM, Holmberg Larsson A, Svensson Gelius S, Kuprin S, Nordling E, Syrén PO. Sci Rep. 2020 Jan 28;10(1):1315.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/31992763"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/31992763"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/31992763"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
